Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 19INDUSTRY 3NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Plasmablastic Lymphoma 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Hodgkin Disease 1HIV Infections 1Burkitt Lymphoma 1

Interventions

Specimen Handling 67Magnetic Resonance Spectroscopy 52Cyclophosphamide 45Vincristine 37Cisplatin 31Radiotherapy 30Radiation 30Carboplatin 29Dexamethasone 28Etoposide 26Biopsy 26Doxorubicin 24daratumumab 18Prednisone 18Radiotherapy, Intensity-Modulated 17durvalumab 16Platinum 16Irinotecan 16Cytarabine 16Paclitaxel 15Gemcitabine 151,2-diaminocyclohexaneplatinum II citrate 15Methotrexate 14Leucovorin 14Docetaxel 14Observation 13Lenalidomide 13Radiotherapy, Conformal 12Fluorouracil 12Calcium Dobesilate 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Carmustine × 1 year × Clear all
NCT02797470 2026-05-18

Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant

AIDS Malignancy Consortium

Phase 1/2 Active not recruiting
11 enrolled 9 charts
Lymphoid

Plasmablastic Lymphoma, Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, HIV Infections, Lymphoma, T-Cell, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡